← Back to Search

Personalized Feedback for Chronic Pain with Substance Use

N/A
Recruiting
Research Sponsored by Syracuse University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Current use of prescription opioid medications.
≥ 21 years of age
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline and 3 month follow-up
Awards & highlights

Study Summary

This trial will develop a computer-based intervention to reduce hazardous drinking and concurrent use of alcohol and prescription opioids among people with chronic pain.

Who is the study for?
This trial is for adults over 21 with chronic pain who drink alcohol hazardously and are currently using prescription opioids. It's not for those who don't speak English, have severe mental health issues, or are already in treatment for substance use.Check my eligibility
What is being tested?
The study tests a computer-based feedback program designed to educate about the risks of mixing alcohol with opioid medications and motivate a reduction in hazardous drinking among chronic pain patients.See study design
What are the potential side effects?
Since this intervention involves psychological feedback rather than medication, traditional side effects aren't expected. However, participants may experience discomfort discussing personal habits related to alcohol and opioid use.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am currently taking prescription opioid medications.
Select...
I am 21 years old or older.
Select...
I experience ongoing pain.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline and 3 month follow-up
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline and 3 month follow-up for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Change in attitudes and intentions to co-use alcohol and opioids
Change in expectancies for pain-coping/reduction via drinking
Change in frequency of alcohol-opioid co-use
+3 more

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Pain-Alcohol Personalized Feedback InterventionExperimental Treatment1 Intervention
Group II: Control Personalized Feedback InterventionActive Control1 Intervention

Find a Location

Who is running the clinical trial?

National Institute on Alcohol Abuse and Alcoholism (NIAAA)NIH
800 Previous Clinical Trials
1,362,802 Total Patients Enrolled
Syracuse UniversityLead Sponsor
48 Previous Clinical Trials
117,379 Total Patients Enrolled

Media Library

Pain-Alcohol Personalized Feedback Intervention Clinical Trial Eligibility Overview. Trial Name: NCT04592978 — N/A
Psychological Feedback Research Study Groups: Control Personalized Feedback Intervention, Pain-Alcohol Personalized Feedback Intervention
Psychological Feedback Clinical Trial 2023: Pain-Alcohol Personalized Feedback Intervention Highlights & Side Effects. Trial Name: NCT04592978 — N/A
Pain-Alcohol Personalized Feedback Intervention 2023 Treatment Timeline for Medical Study. Trial Name: NCT04592978 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is recruitment for this trial ongoing at the present time?

"This clinical trial is currently recruiting, according to its listing on clinicaltrials.gov. It was initially listed on July 30th 2021 and underwent a recent update in June 21st 2022."

Answered by AI

How many individuals will be enrolled in this clinical research?

"Affirmative. According to clinicaltrials.gov, this research is still accepting enrollees since it was first posted on July 30th 2021 and last updated on June 21st 2022. It requires 195 participants that can be sourced from a single medical centre."

Answered by AI
~11 spots leftby Jun 2024